{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T17:13:43Z","timestamp":1774458823418,"version":"3.50.1"},"reference-count":37,"publisher":"Impact Journals, LLC","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,3,29]]},"DOI":"10.18632\/oncotarget.7855","type":"journal-article","created":{"date-parts":[[2016,3,3]],"date-time":"2016-03-03T03:25:59Z","timestamp":1456975559000},"page":"15329-15338","source":"Crossref","is-referenced-by-count":11,"title":["Altered expression of neuropeptide Y receptors caused by focal cortical dysplasia in human intractable epilepsy"],"prefix":"10.18632","volume":"7","author":[{"given":"Lin","family":"Li","sequence":"first","affiliation":[{"name":"Department of Functional Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, P.R. China"},{"name":"Beijing Key Laboratory in Epilepsy, Beijing, P.R. China"},{"name":"Center of Epilepsy, Beijing Institute for Brain Disorders, Beijing, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahui","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Functional Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, P.R. China"},{"name":"Beijing Key Laboratory in Epilepsy, Beijing, P.R. China"},{"name":"Center of Epilepsy, Beijing Institute for Brain Disorders, Beijing, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changqing","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Functional Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanjiang","family":"Luo","sequence":"additional","affiliation":[{"name":"Beijing Key Laboratory of Neural Regeneration and Repair, Department of Neurobiology, Beijing Institute for Brain Disorders, Capital Medical University, Beijing, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuguang","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Functional Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Functional Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueling","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Functional Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianfu","family":"Li","sequence":"additional","affiliation":[{"name":"Beijing Key Laboratory in Epilepsy, Beijing, P.R. China"},{"name":"Center of Epilepsy, Beijing Institute for Brain Disorders, Beijing, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqing David","family":"Xu","sequence":"additional","affiliation":[{"name":"Center of Epilepsy, Beijing Institute for Brain Disorders, Beijing, P.R. China"},{"name":"Beijing Key Laboratory of Neural Regeneration and Repair, Department of Neurobiology, Beijing Institute for Brain Disorders, Capital Medical University, Beijing, P.R. China"},{"name":"Department of Neuroscience, Karolinska Institute, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Ming","family":"Luan","sequence":"additional","affiliation":[{"name":"Department of Functional Neurosurgery, Sanbo Brain Hospital, Capital Medical University, Beijing, P.R. China"},{"name":"Beijing Key Laboratory in Epilepsy, Beijing, P.R. China"},{"name":"Center of Epilepsy, Beijing Institute for Brain Disorders, Beijing, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,3,2]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1136\/jnnp.34.4.369","article-title":"Focal dysplasia of the cerebral cortex in epilepsy","volume":"34","author":"Corsellis","year":"1971","journal-title":"Journal of neurology, neurosurgery, and psychiatry"},{"key":"2","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1212\/01.WNL.0000114507.30388.7E","article-title":"Terminology and classification of the cortical dysplasias","volume":"62","author":"Vinters","year":"2004","journal-title":"Neurology"},{"key":"3","first-page":"821","article-title":"Excitation and inhibition in temporal lobe epilepsy: a close encounter","volume":"79","author":"Ben-Ari","year":"1999","journal-title":"Advances in neurology"},{"key":"4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00401-003-0673-6","article-title":"Cajal-Retzius cells, inhibitory interneuronal populations and neuropeptide Y expression in focal cortical dysplasia and microdysgenesis","volume":"105","author":"Sisodiya","year":"2003","journal-title":"Acta neuropathologica"},{"key":"5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.eplepsyres.2009.09.021","article-title":"Calretinin immunoreactivity in focal cortical dysplasias and in non-malformed epileptic cortex","volume":"88","author":"Zamecnik","year":"2010","journal-title":"Epilepsy research"},{"key":"6","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/153537020322800301","article-title":"Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes","volume":"228","author":"Gehlert","year":"2003","journal-title":"Experimental biology and medicine"},{"key":"7","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1523\/JNEUROSCI.21-15-05804.2001","article-title":"Plasticity of Y1 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy","volume":"21","author":"Sperk","year":"2001","journal-title":"The Journal of Neuroscience"},{"key":"8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.yebeh.2010.09.008","article-title":"Seizure-induced changes in neuropeptide Y-containing cortical neurons: Potential role for seizure threshold and epileptogenesis","volume":"19","author":"Lukoyanov","year":"2010","journal-title":"Epilepsy & behavior"},{"key":"9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0920-1211(96)00059-9","article-title":"Functional changes in somatostatin and neuropeptide Y containing neurons in the rat hippocampus in chronic models of limbic seizures","volume":"26","author":"Sperk","year":"1996","journal-title":"Epilepsy research"},{"key":"10","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.2174\/156802607782340975","article-title":"Clinical potential of neuropeptide Y receptor ligands in the treatment of epilepsy","volume":"7","author":"Smolders","year":"2007","journal-title":"Current topics in medicinal chemistry"},{"key":"11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1113\/jphysiol.1987.sp016409","article-title":"Presynaptic action of neuropeptide Y in area CA1 of the rat hippocampal slice","volume":"383","author":"Pittman","year":"1987","journal-title":"The Journal of physiology"},{"key":"12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0166-2236(98)01284-3","article-title":"Neuropeptide Y: emerging evidence for a functional role in seizure modulation","volume":"22","author":"Colmers","year":"1999","journal-title":"Trends in neurosciences"},{"key":"13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0006-8993(89)90234-5","article-title":"Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy","volume":"495","author":"Spencer","year":"1989","journal-title":"Brain research"},{"key":"14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1124\/mol.53.1.6","article-title":"Up-regulation of neuropeptide Y-Y2 receptors in an animal model of temporal lobe epilepsy","volume":"53","author":"Sperk","year":"1998","journal-title":"Molecular pharmacology"},{"key":"15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0306-4522(95)00332-D","article-title":"Autoradiographic analysis of neuropeptide Y receptor binding sites in the rat hippocampus after kainic acid-induced limbic seizures","volume":"70","author":"Sperk","year":"1996","journal-title":"Neuroscience"},{"key":"16","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0304-3940(99)00381-X","article-title":"Neuropeptide Y suppresses epileptiform activity in rat frontal cortex and hippocampusdifferent NPY receptor subtypes","volume":"268","author":"Bijak","year":"1999","journal-title":"Neurosci Lett"},{"key":"17","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1152\/jn.1997.78.3.1651","article-title":"Neuropeptide Y suppresses epileptiform activity in rat hippocampus","volume":"78","author":"Colmers","year":"1997","journal-title":"Journal of neurophysiology"},{"key":"18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0306-4522(96)00639-2","article-title":"Characterization of neuropeptide Y receptor subtypes in the normal human brain, including the hypothalamus","volume":"79","author":"Quirion","year":"1997","journal-title":"Neuroscience"},{"key":"19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1476-5381.1991.tb12129.x","article-title":"Presynaptic inhibition by neuropeptide Y in rat hippocampal sliceis mediated by a Y2 receptor","volume":"102","author":"Treherne","year":"1991","journal-title":"British journal of pharmacology"},{"key":"20","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/sj.bjp.0704751","article-title":"Blockade of neuropeptide Y(2) receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246","volume":"136","author":"Colmers","year":"2002","journal-title":"British journal of pharmacology"},{"key":"21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.npep.2004.05.004","article-title":"Overexpression of NPY and Y2 receptors in epileptic brain tissue: an endogenous neuroprotective mechanism in temporal lobe epilepsy?","volume":"38","author":"Sperk","year":"2004","journal-title":"Neuropeptides"},{"issue":"Suppl 5","key":"22","first-page":"152","article-title":"Altered expression of neuropeptide Y, -Y(1), and -Y(2) receptors in the hippocampus of patients with mesial temporal lobe epilepsy","volume":"43","author":"Sperk","year":"2002","journal-title":"Epilepsia"},{"key":"23","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0306-4522(02)00545-6","article-title":"Differential changes in messenger RNA expressions and binding sites of neuropeptide Y Y1, Y2 and Y5 receptors in the hippocampus of an epileptic mutant rat: Noda epileptic rat","volume":"115","author":"Kato","year":"2002","journal-title":"Neuroscience"},{"key":"24","doi-asserted-by":"crossref","first-page":"17125","DOI":"10.1073\/pnas.012481899","article-title":"Differential modulation of synaptic transmission by neuropeptide Y in rat neocortical neurons","volume":"99","author":"Prince","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/(SICI)1098-2396(199602)22:2<139::AID-SYN7>3.0.CO;2-E","article-title":"Autoradiographic distribution of [125I]Leu31, Pro34]PYY and [125I]PYY3-36 binding sites in the rat brain evaluated with two newly developed Y1 and Y2 receptor radioligands","volume":"22","author":"Quirion","year":"1996","journal-title":"Synapse"},{"key":"26","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0022-3565(25)24459-7","article-title":"Characterization of neuropeptide Y binding sites in rat brain membrane preparations using [125I][Leu31, Pro34]peptide YY and [125I]peptide YY3-36 as selective Y1 and Y2 radioligands","volume":"272","author":"Quirion","year":"1995","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"27","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/j.1460-9568.1993.tb00231.x","article-title":"Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system","volume":"5","author":"Mikkelsen","year":"1993","journal-title":"The European journal of neuroscience"},{"key":"28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1523\/JNEUROSCI.13-01-00073.1993","article-title":"Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain","volume":"13","author":"Quirion","year":"1993","journal-title":"The Journal of neuroscience"},{"key":"29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/emmm.201000100","article-title":"Therapeutic potential of neuropeptide Y (NPY) receptor ligands","volume":"2","author":"Wahlestedt","year":"2010","journal-title":"EMBO molecular medicine"},{"key":"30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.yebeh.2011.04.064","article-title":"Anxiety symptoms in epilepsy: salient issues for future research","volume":"22","author":"Mula","year":"2011","journal-title":"Epilepsy & behavior"},{"issue":"Suppl 4","key":"31","first-page":"S20","article-title":"Epilepsy and anxiety","volume":"4","author":"Devinsky","year":"2003","journal-title":"Epilepsy & behavior"},{"key":"32","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.nbd.2005.05.010","article-title":"Differential suppression of seizuresY2 and Y5 neuropeptide Y receptors","volume":"20","author":"Kokaia","year":"2005","journal-title":"Neurobiology of disease"},{"key":"33","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.nbd.2011.08.012","article-title":"Combined gene overexpression of neuropeptide Y and its receptor Y5 in the hippocampus suppresses seizures","volume":"45","author":"Kokaia","year":"2012","journal-title":"Neurobiology of disease"},{"key":"34","doi-asserted-by":"crossref","first-page":"13518","DOI":"10.1073\/pnas.96.23.13518","article-title":"Role of the Y5 neuropeptide Y receptor in limbic seizures","volume":"96","author":"Palmiter","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"35","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/(SICI)1099-1387(200003)6:3<97::AID-PSC236>3.0.CO;2-E","article-title":"Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family","volume":"6","author":"Beck-Sickinger","year":"2000","journal-title":"Journal of peptide science"},{"key":"36","doi-asserted-by":"crossref","first-page":"764","DOI":"10.2174\/0929867320666131119154018","article-title":"Receptors of peptides as therapeutic targets in epilepsy research","volume":"21","author":"Kovacs","year":"2014","journal-title":"Current medicinal chemistry"},{"key":"37","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1528-1167.2010.02777.x","article-title":"The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission","volume":"52","author":"Cross","year":"2011","journal-title":"Epilepsia"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7855","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T16:12:48Z","timestamp":1748794368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.7855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,2]]},"references-count":37,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2016,3,29]]}},"alternative-id":["7855","26943580"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.7855","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,2]]}}}